AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15361722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir (14 mg/kg divided twice daily)
Number of subjects: 425
Study 15361722 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (45/6.4 mg/kg divided twice daily)
Number of subjects: 425
Study 15361722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir
Number of subjects: 425
Study 15361722 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate
Number of subjects: 425
Study 11348041 — intervention group
Group type: EXPERIMENTAL
Intervention: Late reperfusion (n=22)
Number of subjects: 44
Study 11348041 — intervention group
Group type: COMPARATOR
Intervention: Non-reperfusion (n=22)
Number of subjects: 44
Study 9730792 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine bronchial challenge in divers
Number of subjects: 59
Study 9730792 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial challenge tests
Number of subjects: 59
Study 7518981 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin (10 mg once daily)
Number of subjects: 996
Study 7518981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 996
Study 7518981 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 996
Study 2574673 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonium chloride (urinary pH 5.2)
Number of subjects: 10
Study 2574673 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hydrogen carbonate (urinary pH 7.8)
Number of subjects: 10
Study 4597122 — intervention group
Group type: EXPERIMENTAL
Intervention: Metiamide
Number of subjects: 14
Study 4597122 — intervention group
Group type: EXPERIMENTAL
Intervention: Metiamide (infused intravenously or intraduodenally)
Number of subjects: 14
Study 30992108 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual intervention (animated video)
Number of subjects: 40
Study 30992108 — intervention group
Group type: COMPARATOR
Intervention: Standardized verbal instructions (control group)
Number of subjects: 40
Study 27557589 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% salicylic acid peels
Number of subjects: 40
Study 27557589 — intervention group
Group type: COMPARATOR
Intervention: Jessner's solution peels
Number of subjects: 40
Study 26577771 — intervention group
Group type: EXPERIMENTAL
Intervention: SB2
Number of subjects: 159
Study 26577771 — intervention group
Group type: COMPARATOR
Intervention: EU‐sourced INF (EU‐INF)
Number of subjects: 159
Study 26577771 — intervention group
Group type: COMPARATOR
Intervention: US‐sourced INF (US‐INF)
Number of subjects: 159
Study 23192698 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol ablation (AA)
Number of subjects: 40
Study 23192698 — intervention group
Group type: COMPARATOR
Intervention: Repeated thermal radiofrequency ablation (RFA)
Number of subjects: 40
Study 21355157 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (GB 37, BL 1, BL 2, EX-HN 5, ST 2, GB 14, GB 1, GB 20, BL 18, BL 23, ST 40)
Number of subjects: 84
Study 21355157 — intervention group
Group type: COMPARATOR
Intervention: Medication (Vitamin C, Vitamin E, and Entodon)
Number of subjects: 84
Study 19426524 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered secondary prevention program (ProActive Heart) consisting of up to 10 x 30 minute scripted telephone health coaching sessions, a ProActive Heart handbook, and an educational resource.
Number of subjects: 550
Study 19426524 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified in the abstract).
Number of subjects: 550
Study 21468626 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) for 12 weeks
Number of subjects: 45
Study 21468626 — intervention group
Group type: COMPARATOR
Intervention: Hormone therapy (HT) for 24 months
Number of subjects: 45
Study 15754345 — intervention group
Group type: EXPERIMENTAL
Intervention: Purpose-designed needle and sampling technique
Number of subjects: 23
Study 11896626 — intervention group
Group type: COMPARATOR
Intervention: CCND1 870A allele in familial cases
Number of subjects: 377
Study 11896626 — intervention group
Group type: COMPARATOR
Intervention: CCND1 870A allele in sporadic cases
Number of subjects: 377
Study 11896626 — intervention group
Group type: COMPARATOR
Intervention: CDH1 ‐160A/C genotypes
Number of subjects: 377
Study 11896626 — intervention group
Group type: COMPARATOR
Intervention: Low expressing A allele of CDH1
Number of subjects: 377
Study 9857532 — intervention group
Group type: EXPERIMENTAL
Intervention: Autovaccine
Number of subjects: 0
Study 7833310 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised vaginal ultrasound technique
Number of subjects: 160
Study 2211568 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone 5 mg t.i.d.
Number of subjects: 72
Study 2211568 — intervention group
Group type: COMPARATOR
Intervention: Placebo t.i.d.
Number of subjects: 72
Study 90215 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium dichloromethylene diphosphonate 1600 mg/day
Number of subjects: 19
Study 30499312 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E-diffused highly crosslinked polyethylene (VEPE)
Number of subjects: 208
Study 30499312 — intervention group
Group type: COMPARATOR
Intervention: Moderately crosslinked and mechanically annealed ultra-high molecular weight polyethylene (ModXLPE)
Number of subjects: 208
Study 30499312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic femoral heads
Number of subjects: 208
Study 30499312 — intervention group
Group type: COMPARATOR
Intervention: Metal femoral heads
Number of subjects: 208
Study 26036660 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4)
Number of subjects: 396
Study 26036660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 396
Study 25903752 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC) using a blood pressure cuff with four cycles of 5 minutes of ischaemia followed by 5 minutes of reperfusion immediately before surgery.
Number of subjects: 400
Study 25903752 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 400
Study 23289548 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (1,470 mg docosahexaenoic acid and 147 mg eicosapentaenoic acid daily)
Number of subjects: 140
Study 23289548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 23289548 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation
Number of subjects: 140
Study 20648913 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 53
Study 20648913 — intervention group
Group type: COMPARATOR
Intervention: Support group
Number of subjects: 53
Study 18156429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fat screener (PFat)
Number of subjects: 4
Study 18156429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fruit and vegetable screener (FVS)
Number of subjects: 4
Study 18156429 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-item question on fruit and vegetable intake
Number of subjects: 4
Study 16897200 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural neuroplasty
Number of subjects: 99
Study 16897200 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 99
Study 14703595 — intervention group
Group type: EXPERIMENTAL
Intervention: RDS infants who developed BPD
Number of subjects: 39
Study 14703595 — intervention group
Group type: EXPERIMENTAL
Intervention: RDS infants (both BPD and non-BPD)
Number of subjects: 39
Study 14703595 — intervention group
Group type: COMPARATOR
Intervention: RDS infants who did not develop BPD
Number of subjects: 39
Study 11020623 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaco chop technique
Number of subjects: 242
Study 11020623 — intervention group
Group type: COMPARATOR
Intervention: Divide and conquer technique
Number of subjects: 242
Study 8898139 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 42
Study 8898139 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 42
Study 1832516 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (once a day for 4 days)
Number of subjects: 8
Study 1832516 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 4 days)
Number of subjects: 8
Study 1832516 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (after withdrawal)
Number of subjects: 8
Study 7046331 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 40
Study 7046331 — intervention group
Group type: COMPARATOR
Intervention: Alcuronium
Number of subjects: 40
Study 31878199 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing Sophora japonica
Number of subjects: 150
Study 31878199 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing Ginkgo biloba
Number of subjects: 150
Study 31878199 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing Platanus acerifolia
Number of subjects: 150
Study 31878199 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing Koelreuteria paniculata
Number of subjects: 150
Study 31878199 — intervention group
Group type: COMPARATOR
Intervention: Indoor environment (control)
Number of subjects: 150
Study 28272999 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration of lifetime unemployment
Number of subjects: 1282
Study 27503949 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid (TUDCA, 1500 mg)
Number of subjects: 12
Study 27503949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 24315572 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnographic sleep during inpatient treatment
Number of subjects: 20
Study 24315572 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with positive urine test
Number of subjects: 20
Study 24315572 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep time (TST) compared to number of days abstinent
Number of subjects: 20
Study 22699440 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414
Number of subjects: 684
Study 22699440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 684
Study 20142023 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambrisentan monotherapy
Number of subjects: 12
Study 18388356 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (Acz) 250 mg/d for 12 weeks
Number of subjects: 55
Study 18388356 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (Acz) 250 mg/d for 6 months (after a 4-week washout)
Number of subjects: 55
Study 18388356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 15807672 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg/day on 3 consecutive days per week for the first month, 2 consecutive days per week for the second month, and 1 day per week for the third month.
Number of subjects: 51
Study 15807672 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline twice a day for the first month, once a day for the second and third months.
Number of subjects: 51
Study 15807672 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 51
Study 15807672 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 51
Study 12393820 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy plus breast irradiation
Number of subjects: 1851
Study 12393820 — intervention group
Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 1851
Study 12393820 — intervention group
Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 1851
Study 12393820 — intervention group
Group type: COMPARATOR
Intervention: Postoperative breast irradiation among lumpectomy-treated women with tumor-free margins
Number of subjects: 1851
Study 12393820 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 1851
Study 12038039 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei and L. acidophilus strains CERELA (1.5 g each)
Number of subjects: 22
Study 12038039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 12038039 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei and L. acidophilus strains CERELA
Number of subjects: 22
Study 10217552 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent voucher incentives (n = 19) for each consecutive naltrexone dose ingested
Number of subjects: 58
Study 10217552 — intervention group
Group type: COMPARATOR
Intervention: Non-contingent voucher incentives (n = 19) on unpredictable schedule
Number of subjects: 58
Study 10217552 — intervention group
Group type: COMPARATOR
Intervention: No-voucher group (n = 20)
Number of subjects: 58
Study 10158377 — intervention group
Group type: EXPERIMENTAL
Intervention: Atherectomy treatment of bifurcation lesions
Number of subjects: 1012
Study 10158377 — intervention group
Group type: COMPARATOR
Intervention: Angioplasty treatment of bifurcation lesions
Number of subjects: 1012
Study 2526999 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (220 mg Zn sulfate orally)
Number of subjects: 14
Study 2526999 — intervention group
Group type: COMPARATOR
Intervention: Control group (no zinc supplementation)
Number of subjects: 14
Study 106965 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium‐2‐mercaptoethane sulfonate (ASTA D‐7093; mesnum) administered intravenously to 11 patients
Number of subjects: 20
Study 106965 — intervention group
Group type: COMPARATOR
Intervention: standard prophylaxis administered to 9 patients
Number of subjects: 20
Study 31939923 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT‐DSAEK)
Number of subjects: 38
Study 31939923 — intervention group
Group type: EXPERIMENTAL
Intervention: Descemet Membrane Endothelial Keratoplasty (DMEK)
Number of subjects: 38
Study 30610021 — intervention group
Group type: EXPERIMENTAL
Intervention: MSMW
Number of subjects: 1809
Study 30610021 — intervention group
Group type: COMPARATOR
Intervention: MSMO
Number of subjects: 1809
Study 29179734 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital cessation intervention (WEB + TXT)
Number of subjects: 1650
Study 29179734 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital cessation intervention combined with tobacco treatment specialist (TTS) counseling (WEB + TXT + TTS)
Number of subjects: 1650
Study 29179734 — intervention group
Group type: COMPARATOR
Intervention: Usual care control condition (UC) which consists of Ask-Advise-Refer
Number of subjects: 1650
Study 25754008 — intervention group
Group type: EXPERIMENTAL
Intervention: FEMTO LDV Crystal Line femtosecond laser and WaveLight Allegretto Eye‐Q 400 Hz excimer laser
Number of subjects: 444
Study 23332672 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-year multidomain intervention consisting of nutritional guidance, exercise, cognitive training and social activity, and management of metabolic and vascular risk factors
Number of subjects: 1200
Study 23332672 — intervention group
Group type: COMPARATOR
Intervention: Regular health advice
Number of subjects: 1200
Study 23332672 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-year multidomain intervention
Number of subjects: 1200
Study 21855592 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 μg ID-TIV
Number of subjects: 112
Study 21855592 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 μg ID-TIV
Number of subjects: 112
Study 21855592 — intervention group
Group type: COMPARATOR
Intervention: 15 μg IM VA-TIV
Number of subjects: 112
Study 19502859 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue staining
Number of subjects: 50
Study 19502859 — intervention group
Group type: COMPARATOR
Intervention: Standard nodal harvest (unstained)
Number of subjects: 50
Study 18000144 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-paced walking
Number of subjects: 3035
Study 18000144 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual-paced walking
Number of subjects: 3035
Study 18000144 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported measures of physical function (including ADLs)
Number of subjects: 3035
Study 15482051 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous Internet‐delivered intervention (chat room) for improving eating habits and body image
Number of subjects: 60
Study 15482051 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 60
Study 11853301 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower uterine segment sweeping
Number of subjects: 400
Study 11853301 — intervention group
Group type: COMPARATOR
Intervention: Routine vaginal examination (Control)
Number of subjects: 400
Study 9209168 — intervention group
Group type: COMPARATOR
Intervention: 0 g soy protein
Number of subjects: 14
Study 9209168 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g soy protein
Number of subjects: 14
Study 9209168 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g soy protein
Number of subjects: 14
Study 9209168 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g soy protein
Number of subjects: 14
Study 16353603 — intervention group
Group type: EXPERIMENTAL
Intervention: Etiocholanedione (ED), 4 gm daily
Number of subjects: 14
Study 16353603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2454359 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute administration of carvedilol (50 mg)
Number of subjects: 0
Study 2454359 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic administration of carvedilol
Number of subjects: 0
Study 29414482 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-session couple-based HIV/HCV and overdose prevention intervention
Number of subjects: 479
Study 29414482 — intervention group
Group type: COMPARATOR
Intervention: 5-session Wellness Promotion and overdose prevention comparison condition
Number of subjects: 479
Study 26796609 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 minimum alveolar concentration of desflurane and 1.0 ng/mL effect‐site concentration of remifentanil (group DR)
Number of subjects: 62
Study 26796609 — intervention group
Group type: COMPARATOR
Intervention: 1.5 minimum alveolar concentration desflurane (group D)
Number of subjects: 62
Study 24942380 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy with 10 J dose
Number of subjects: 40
Study 24942380 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy with 30 J dose
Number of subjects: 40
Study 24942380 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy with 50 J dose
Number of subjects: 40
Study 24942380 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy with all doses (10 J, 30 J, 50 J)
Number of subjects: 40
Study 22228000 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and high intravenous (IV) amino acid (AA) supplementation starting at 0.5 g.kg(-1).day(-1) and increased to 3 g.kg(-1).day(-1)
Number of subjects: 51
Study 22228000 — intervention group
Group type: COMPARATOR
Intervention: Standard intravenous (IV) amino acid (AA) supplementation starting at 2 g.kg(-1).day(-1) and increased to 4 g.kg(-1).day(-1)
Number of subjects: 51
Study 20051728 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stretching (group 1)
Number of subjects: 65
Study 20051728 — intervention group
Group type: COMPARATOR
Intervention: Passive stretching (group 2)
Number of subjects: 65
Study 18552370 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised training programme (very light resistance and toning exercises, 80 sessions, 3 times/week, 35 min/session from weeks 12-13 to weeks 38-39)
Number of subjects: 142
Study 18552370 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 142
Study 16396746 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental protocols in randomized controlled trials (RCT) for pediatric cancers
Number of subjects: 0
Study 16396746 — intervention group
Group type: COMPARATOR
Intervention: Reference treatment modalities
Number of subjects: 0
Study 15354622 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based depressive symptom intervention with master's-prepared psychiatric mental health nurses
Number of subjects: 16
Study 15354622 — intervention group
Group type: COMPARATOR
Intervention: Usual care/waiting list
Number of subjects: 16
Study 15354622 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based depressive symptom intervention
Number of subjects: 16
Study 10953194 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplantation of cultured human neuronal cells
Number of subjects: 12
Study 8666628 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement
Number of subjects: 76
Study 8666628 — intervention group
Group type: COMPARATOR
Intervention: Washout
Number of subjects: 76
Study 1486224 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (MCF: mitoxantrone, cyclophosphamide, 5‐fluorouracil)
Number of subjects: 40
Study 6428372 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (mean dose, 2.95 mg/day)
Number of subjects: 61
Study 6428372 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (mean dose, 1,166 mg/day)
Number of subjects: 61
Study 6428372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 3549803 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily 2% topical minoxidil for 12 months
Number of subjects: 41
Study 3549803 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% topical minoxidil for 8 to 12 months followed by twice-daily application for 1 more year
Number of subjects: 41
Study 3549803 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily topical minoxidil after 2 years
Number of subjects: 41
Study 3549803 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily topical minoxidil throughout the study
Number of subjects: 41
Study 3549803 — intervention group
Group type: COMPARATOR
Intervention: Placebo for the first 4 months
Number of subjects: 41
Study 30520168 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 50 μg/g plus betamethasone dipropionate 0.5 mg/g cutaneous foam (Cal/BD foam)
Number of subjects: 837
Study 28899341 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based training program (12 weeks) including exercises to improve strength/power, postural control, individual walking trails, and patient-specific motivational strategies
Number of subjects: 101
Study 28899341 — intervention group
Group type: COMPARATOR
Intervention: Unspecific flexibility exercise (12 weeks)
Number of subjects: 101